Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617 1645
This examiner grants 56% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17793755 | NOVEL ADDITIVES FOR AGROCHEMICAL FORMULATIONS | Non-Final OA | BASF SE |
| 18128271 | SOLID DEODORIZER FOR CONCEALING A VISUAL INDICATOR ASSOCIATED WITH PRODUCT LIFE SIGNAL | Final Rejection | The Procter & Gamble Company |
| 17834994 | ORAL PRODUCT WITH SUSTAINED FLAVOR RELEASE | Non-Final OA | NICOVENTURES TRADING LIMITED |
| 16007041 | AUXIN HERBICIDAL MIXTURES | Final Rejection | Monsanto Technology LLC |
| 17195819 | PIGMENT COMPOSITION FOR SEED COATINGS | Final Rejection | Sun Chemical Corporation |
| 18551766 | SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | Non-Final OA | Bayer Aktiengesellschaft |
| 18641369 | DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM | Final Rejection | The Trustees of Princeton University |
| 18662545 | MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE | Non-Final OA | Università degli Studi di Milano |
| 18651700 | USE OF HIGHER ALIPHATIC ALCOHOL IN IMPROVING NITROGEN FIXING CAPACITY AND DROUGHT RESISTANCE CAPACITY OF LEGUMES | Non-Final OA | Zhuhai Runnong Science and Technology Co. Ltd |
| 18644608 | MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION | Non-Final OA | The United States Government, as Represented by the Department of Veterans Affairs |
| 18592784 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI | Non-Final OA | RedHill Biopharma Ltd. |
| 18326585 | BANDING SOLUTION FOR MANUFACTURING ENTERIC HARD CAPSULES AND ENTERIC HARD CAPSULE MANUFACTURED USING THE SAME | Non-Final OA | SUHEUNG CO., LTD. |
| 18394634 | ELASTIC ADHESIVE COMPRESSION DRESSING | Final Rejection | RETIYA MEDICAL SOLUTIONS |
| 18386327 | GOLD NANO-DELIVERY SYSTEM FOR PAIN AND CANCER THERAPY | Non-Final OA | Toronto Poly Clinic Inc. |
| 18453429 | Premoistened Wipes with Virucidal Properties Against Non-Enveloped Viruses | Non-Final OA | ARXADA, LLC |
| 18266870 | USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME | Non-Final OA | CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD |
| 18257605 | ANTIOXIDANT NUTRITIONAL SUPPLEMENT FOR IMMUNE SYSTEM SUPPORT | Non-Final OA | VIVA NATURALS, INC. |
| 18206895 | Brain Targeted Nutritional Therapeutic for Improved Cognitive Function and Treatment of Mild Cognitive Impairment | Non-Final OA | BRAINCARE LLC |
| 17764322 | OSELTAMIVIR FORMULATION | Non-Final OA | SUNSHINE LAKE PHARMA CO., LTD. |
| 18140414 | WOUND-CLEANSING PAD APPARATUS AND METHODS OF USE | Non-Final OA | Farrow Medtech, LLC |
| 18248925 | Hybrid Micro Molding-Fiber Deposition Substrate Processing for Cell Biology Manipulation and Local Anisotropy | Final Rejection | Ri.MED FOUNDATION |
| 18295520 | CONTACT LENS COMPOSITIONS AND METHODS OF USE THEREOF | Non-Final OA | PS Therapy, Inc. |
| 17627221 | HERBICIDAL COMPOSITION CONTAINING R-TYPE PYRIDYLOXY CARBOXYLIC ACID DERIVATIVE AND USE THEREOF | Non-Final OA | Qingdao Kingagroot Chemical Compound Co., Ltd. |
| 18158156 | HAEMOSTATIC MATERIAL | Non-Final OA | Medtrade Products Limited |
| 18005224 | SUPER ABSORBENT POLYMERIC FOAM | Non-Final OA | UPL DO BRASIL INDUSTRIA E COMERCIO DE INSUMOS AGROPECUARIOS S.A. |
| 17917407 | COMPOSITIONS AND METHODS FOR TREATING VIRUSES | Final Rejection | Elias Reichel |
| 17909869 | ANTISEPTIC-ANTIBIOTIC GUMBOS EFFECTIVE AGAINST GRAM-NEGATIVE PATHOGENS | Final Rejection | Board of Supervisors of Lousiana State University and Agricultural and Mechanical College |
| 17770640 | USE OF STARCH NANOPARTICLES LOADED WITH ACTIVE MOLECULES FOR AQUACULTURE | Non-Final OA | UNIVERSITÉ DU LITTORAL CÔTE D'OPALE |
| 17533942 | OPTHALMOLOGICAL COMPOSITIONS AND METHODS OF USE THEREOF | Non-Final OA | PS Therapy Ltd |
| 17279777 | TREATMENT OF DEMENTIA-ASSOCIATED TAUOPATHIES | Non-Final OA | Deutsches Zentrum Fur Neurodegenerative Erkrankungen E.V. (DZNE) |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy